Ahmad Moh’d Awad Al Nawaiseh, MD

Clinical Instructor, Medical Sciences & Education

Ahmad Al Nawaiseh
617.358.9600
72 E. Concord St.

Publications

  • Published on 11/10/2023

    Nawaiseh MB, Yassin AM, Al-Sabbagh MQ, AlNawaiseh A, Zureigat H, Aljbour AlMajali D, Haddadin RR, El-Ghanem M, Abu-Rub M. Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events. Neurol Clin Pract. 2024 Feb; 14(1):e200215. PMID: 38173541.

    Read at: PubMed
  • Published on 5/3/2023

    Yassin A, Nawaiseh M, Al-Sabbagh MQA, AlNawaiseh A, Abu-Rub M. Neurological findings in sickle cell disease patients without a history of neurological insult: prevalence, risk factors and practice implications. Neurology. 2023; P5-12.001.

  • Published on 11/30/2022

    Hawari FI, Abu Alhalawa MA, Alshraiedeh RH, Al Nawaiseh AM, Khamis A, Dodin YI, Obeidat NA. Supporting Smokers in Difficult Settings: Suggestions for Better Education and Counseling in Cancer Centers in Jordan. Curr Oncol. 2022 Nov 30; 29(12):9335-9348. PMID: 36547146.

    Read at: PubMed
  • Published on 6/24/2022

    Hawari FI, Abu Alhalawa MA, Alshrideh RH, Al Nawaiseh AM, Khamis A, Dodin YI, Obeidat NA. Cessation experiences and quitting perspectives of Jordanian cancer patients who smoke. Cancer Epidemiol. 2022 Aug; 79:102207. PMID: 35759876.

    Read at: PubMed
  • Published on 4/1/2021

    Abu-Yaghi NE, AlNawaiseh AM, Khourshid IM, AlRawashdeh TJ, Rawashdeh MMA, Zghoul AM, Shafagoj AN, Alomairi YA, Muhsen SM, AlRyalat SS. Central macular thickness in patients with sickle cell disease and no signs of retinopathy: a cross-sectional study of Jordanian patients. J Int Med Res. 2021 Apr; 49(4):300060520977387. PMID: 33827305.

    Read at: PubMed

View all profiles